Canlyniadau Chwilio - Gasparini, Alessandro

Estimating latent, dynamic processes of breast cancer tumour growth and distant metastatic spread from mammography screening data gan Gasparini, Alessandro, Humphreys, Keith

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records gan Friberg, Leif, Gasparini, Alessandro, Carrero, Juan Jesus

Cael y testun llawn Cael y testun llawn Cael y testun llawn

INTEREST: INteractive Tool for Exploring REsults from Simulation sTudies gan Gasparini, Alessandro, Morris, Tim P., Crowther, Michael J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Assessing lead time bias due to mammography screening on estimates of loss in life expectancy gan Syriopoulou, Elisavet, Gasparini, Alessandro, Humphreys, Keith, Andersson, Therese M.-L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study gan Lundström, Ulrika Hahn, Gasparini, Alessandro, Bellocco, Rino, Qureshi, Abdul Rashid, Carrero, Juan-Jesus, Evans, Marie

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project gan Gasparini, Alessandro, Evans, Marie, Barany, Peter, Xu, Hairong, Jernberg, Tomas, Ärnlöv, Johan, Lund, Lars H, Carrero, Juan-Jesús

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project gan Runesson, Björn, Qureshi, Abdul R., Xu, Hong, Gasparini, Alessandro, Lindholm, Bengt, Barany, Peter, Elinder, Carl G., Carrero, Juan J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction gan Szummer, Karolina, Gasparini, Alessandro, Eliasson, Staffan, Ärnlöv, Johan, Qureshi, Abdul Rashid, Bárány, Peter, Evans, Marie, Friberg, Leif, Carrero, Juan Jesus

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Mixed‐effects models for health care longitudinal data with an informative visiting process: A Monte Carlo simulation study gan Gasparini, Alessandro, Abrams, Keith R., Barrett, Jessica K., Major, Rupert W., Sweeting, Michael J., Brunskill, Nigel J., Crowther, Michael J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Assessing the Course of Organ Dysfunction Using Joint Longitudinal and Time-to-Event Modeling in the Vasopressin and Septic Shock Trial gan Harhay, Michael O., Gasparini, Alessandro, Walkey, Allan J., Weissman, Gary E., Crowther, Michael J., Ratcliffe, Sarah J., Russell, James A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism gan Evans, Marie, Methven, Shona, Gasparini, Alessandro, Barany, Peter, Birnie, Kate, MacNeill, Stephanie, May, Margaret T., Caskey, Fergus J., Carrero, Juan-Jesus

Cael y testun llawn Cael y testun llawn Cael y testun llawn

eGFR and the Risk of Community-Acquired Infections gan Xu, Hong, Gasparini, Alessandro, Ishigami, Junichi, Mzayen, Khaled, Su, Guobin, Barany, Peter, Ärnlöv, Johan, Lindholm, Bengt, Elinder, Carl Gustaf, Matsushita, Kunihiro, Carrero, Juan Jesús

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Prevalence and recognition of chronic kidney disease in Stockholm healthcare gan Gasparini, Alessandro, Evans, Marie, Coresh, Josef, Grams, Morgan E., Norin, Olof, Qureshi, Abdul R., Runesson, Björn, Barany, Peter, Ärnlöv, Johan, Jernberg, Tomas, Wettermark, Björn, Elinder, Carl G., Carrero, Juan-Jesüs

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project gan Bandak, Ghassan, Sang, Yingying, Gasparini, Alessandro, Chang, Alex R., Ballew, Shoshana H., Evans, Marie, Arnlov, Johan, Lund, Lars H., Inker, Lesley A., Coresh, Josef, Carrero, Juan‐Jesus, Grams, Morgan E.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Lower serum calcium is independently associated with CKD progression gan Janmaat, Cynthia J., van Diepen, Merel, Gasparini, Alessandro, Evans, Marie, Qureshi, Abdul Rashid, Ärnlöv, Johan, Barany, Peter, Elinder, Carl-Gustaf, Rotmans, Joris I., Vervloet, Marc, Dekker, Friedo W., Carrero, Juan Jesus

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care gan Bosi, Alessandro, Xu, Yunwen, Gasparini, Alessandro, Wettermark, Björn, Barany, Peter, Bellocco, Rino, Inker, Lesley A, Chang, Alex R, McAdams-DeMarco, Mara, Grams, Morgan E, Shin, Jung-Im, Carrero, Juan J

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Albuminuria changes and subsequent risk of end-stage renal disease and mortality gan Carrero, Juan J, Grams, Morgan E., Sang, Yingying, Ärnlöv, Johan, Gasparini, Alessandro, Matsushita, Kunihiro, Qureshi, Abdul R, Evans, Marie, Barany, Peter, Lindholm, Bengt, Ballew, Shoshana H., Levey, Andrew S, Gansevoort, Ron T, Elinder, Carl G, Coresh, Josef

Cael y testun llawn Cael y testun llawn Cael y testun llawn